Atom Bioscience Receives FDA IND Clearance for Clinical Trial of ABP-745 for Acute Gout
JIANGSU, China--(BUSINESS WIRE)--Jan 2, 2024--
Source: eagletribune.com
Stay updated with breaking news from Royj Wu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JIANGSU, China--(BUSINESS WIRE)--Jan 2, 2024--
ABP-671 effective at lowering serum uric acid, the cause of gout JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today that it will present final dated data from its Phase 2a clinical trial of its s...